ELIGARD is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
| ELIGARD 22.5 mg | ELIGARD 45 mg |
| PRE-CONNECTED SYRINGE SYSTEM | |
| סרטון הדרכה: 2 מזרקים | סרטון הדרכה: מערכת של מזרקים מחוברים מראש |
| INSTRUCTIONS FOR RECONSTITUTION AND ADMINISTRATION FOR ELIGARD PRE-CONNECTED SYRINGE SYSTEM |
